S
Spinal Kinetics
Partners with spine surgeons to develop motion preservation systems for the treatment of degenerative spine diseases
About Spinal Kinetics
Spinal Kinetics, established in 2003 by Tom Afzal, operates as a privately-held medical device company with a sharp focus on motion preservation technologies for the spine. The company targets the market for treating degenerative diseases of the spine, collaborating closely with spine surgeons to bring its products to market. Its business model centers on the development, manufacturing, and sale of these advanced medical devices to healthcare providers and institutions. In May 2018, the medical technology company Orthofix Medical Inc. acquired Spinal Kinetics, a transaction valued at up to $105 million, integrating the M6 disc into its broader portfolio of spine solutions. This acquisition marked a significant milestone, providing Spinal Kinetics with the resources and distribution network of a larger, publicly-traded entity.
The company's flagship product is the M6 Artificial Disc, available for both cervical (neck) and lumbar (lower back) applications. The M6 disc is designed to replicate the natural biomechanics of a healthy intervertebral disc, setting it apart from traditional spinal fusion procedures that immobilize the spinal segment. Its distinctive feature is the incorporation of an artificial nucleus made of polycarbonate urethane and a woven polyethylene fiber annulus, which together mimic the shock-absorbing and movement-enabling qualities of a natural disc. This construction allows for a controlled range of motion in all six degrees, including translation and rotation, aiming to provide patients with a more natural spinal movement post-surgery and potentially reducing the risk of adjacent segment disease.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 2003
- Headquarters
- Sunnyvale, United States
- Employees
- 27
- Open positions
- None listed
- Dealroom signal
- 64.3/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Biotechnology, Orthopedic, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2c
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
Growth signals
Latest recorded traffic for Spinal Kinetics is 640 monthly website visits, up 220% over the last three months. Spinal Kinetics's team declined 12.9% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A6 investors entered at this stage
Scale Venture Partners- DVDeNovo Ventures
HLM Venture Partners- MCMDS Capital
SV Health Investors- AVAscent Biomedical Ventures
Series B and later1 investor entered at this stage
Lumira Ventures
Other known investors1 additional known investor
Orthofix
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Spinal Kinetics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Spinal Kinetics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







